デフォルト表紙
市場調査レポート
商品コード
1466007

経皮吸収パッチの世界市場:製品タイプ、技術、用途、流通チャネル、エンドユーザー別、予測(2024年~2030年)

Transdermal Patches Market by Product, Type, Technology, Application, Distribution Channel, End Users - Global Forecast 2024-2030

出版日: | 発行: 360iResearch | ページ情報: 英文 198 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.74円
経皮吸収パッチの世界市場:製品タイプ、技術、用途、流通チャネル、エンドユーザー別、予測(2024年~2030年)
出版日: 2024年04月17日
発行: 360iResearch
ページ情報: 英文 198 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の経皮吸収パッチの市場規模は、2023年に85億7,000万米ドルと推定され、2024年には98億9,000万米ドルに達し、2030年にはCAGR16.40%で248億4,000万米ドルに達すると予測されています。

経皮吸収パッチは、皮膚から血流に直接薬剤を送り込むことで、慢性疾患を管理する新しい治療アプローチを提供します。これらのパッチは、ニコチン禁煙、ホルモン補充療法、疼痛管理、降圧薬、抗炎症薬、避妊薬の投与など、さまざまな目的で使用されています。経口薬投与が困難な高齢者人口の増加は、経皮吸収パッチの使いやすさの恩恵を受ける可能性があります。慢性疾患の蔓延と非侵襲的ドラッグデリバリーへの嗜好の高まりが、経皮吸収パッチの必要性を高めています。しかし、経皮吸収パッチに関連する高いコストと制限は、エンドユーザーの採用を妨げる可能性があります。さらに、革新的なドラッグデリバリーシステムを開発し、利用可能な経皮ドラッグデリバリーシステムの有効性と範囲を向上させるための継続的な研究開発は、慢性疾患の治療への利用を世界的に促進すると予想されます。

主な市場の統計
基準年 [2023] 85億7,000万米ドル
予測年 [2024] 98億9,000万米ドル
予測年 [2030] 248億4,000万米ドル
CAGR(%) 16.40%

製品:多層接着パッチの大幅な浸透

ニコチン経皮吸収システムは、禁煙のための確立された治療オプションです。ニコチン経皮吸収システムは、タバコの燃焼の副産物を伴わないニコチンの制御された放出により、禁煙しようとする人の禁断症状や欲求を緩和します。このシステムは、長期的な禁煙率の改善において有効性が実証されており、健康に重大な影響を及ぼす慢性疾患であるニコチン依存症に対する効率的な薬物療法と考えられています。鎮痛薬経皮吸収パッチは、関節炎や神経障害性疼痛を含む慢性疼痛の管理において重要な要素である、標的を絞った持続的な鎮痛を提供します。フェンタニルのような薬剤を含むオピオイドパッチは、がん患者のような重度の難治性疼痛に対して強力な鎮痛効果を発揮します。リドカインパッチなどの非オピオイド系は、局所的な症状に対して使用され、全身的な副作用が少なく、依存性のリスクが低いという利点があります。ホルモン補充療法(HRT)パッチは、主に更年期症状の治療と骨粗鬆症の予防に用いられます。血中濃度が一定で、初回通過代謝が少なく、潜在的な副作用を最小限に抑えることができるため、経口剤よりも好む患者もいます。エストロゲンパッチは、閉経後症状を経験する女性の質の向上に大きく貢献しています。降圧剤経皮パッチは、高血圧を制御するのに役立つ薬剤を放出します。高血圧は、管理されないまま放置すると心血管疾患につながる可能性がある一般的な慢性疾患です。これらのパッチは、安定した吸収速度を提供し、一定の血漿中薬物濃度を維持することにより、血圧の変動を回避します。経口投与が困難な患者にとっては有効な選択肢であり、治療レジメンのコンプライアンスが向上します。経皮グルコース管理における新しい技術は、非侵襲的な血糖モニタリングとインスリン送達の可能性を示し、糖尿病管理に革命をもたらします。これらの技術は、従来の指を刺す検査や注射に代わる、便利で苦痛のない方法であり、糖尿病患者の治療へのアドヒアランスを高め、血糖コントロールを改善する可能性があります。

タイプ:ニコチン経皮吸収パッチに対する広範な要求

ブプレノルフィン経皮吸収パッチは疼痛管理に使用されます。オピオイド鎮痛薬が長期間必要と判断された場合に使用されます。完全なオピオイド作動薬に比べ、乱用、副作用、中毒のリスクが低いという利点があります。このパッチは週1回貼付することで、経口投与でみられるピークとスルーの変動を最小限に抑えながら疼痛を緩和します。クロニジン経皮吸収パッチは高血圧症治療薬です。クロニジンは中枢性α作動薬で、心拍数を低下させ血管を弛緩させることにより血圧を低下させます。パッチ製剤は、7日間にわたる安定した薬物投与を可能にし、患者のコンプライアンスを改善し、クロニジンの経口投与に伴う副作用を軽減する可能性があります。フェンタニルは、デュラジェシックのようなパッチを通じて皮膚から投与されます。これらのパッチは、オピオイド治療に慣れた患者において、代替治療法が不十分な場合に、持続性の強い疼痛に使用されます。フェンタニルパッチは72時間にわたって持続的な鎮痛効果をもたらしますが、フェンタニルは強力であるため、呼吸抑制などの危険な副作用を防ぐためには、慎重な患者選択とモニタリングが重要です。ニコチン経皮吸収パッチは、禁煙に伴う禁断症状や欲求を緩和するために、安定した量のニコチンを投与します。ニコチン経皮吸収パッチは、数週間から数ヶ月にわたってニコチンへの曝露をコントロールしながら減少させることで、喫煙者の依存症克服をサポートします。これらのパッチは、ステップダウン療法のプロトコルに対応するため、さまざまな強さのものが用意されています。オキシブチニン経皮吸収パッチは、切迫感、頻尿、失禁などの症状を特徴とする過活動膀胱に苦しむ患者に使用されます。オキシブチニンは膀胱の筋肉を弛緩させる抗ムスカリン薬です。貼付剤では、3~4日間にわたり薬物濃度を一定に保つことができるため、経口剤によく見られる抗コリン性の副作用を最小限に抑えながら、症状の緩和をもたらします。

技術:経皮パッチの有効性を向上させる化学増強剤の利用

化学的増強剤とは、パッチ製剤に配合され、薬物分子の溶解性と皮膚透過性を改善する成分です。これらの増強剤は皮膚の脂質マトリックスを破壊し、薬物の拡散を助けます。電流またはイオントフォレーシス(iontophoresis)は、皮膚を通して薬物やその他の化学物質を送達するために微量の電荷を流す非侵襲的な方法です。イオンを皮膚上で電気泳動させることにより薬物の浸透を促進し、薬物を直接全身循環に導入します。これにより、初回通過代謝の弊害が回避され、薬物のバイオアベイラビリティが向上します。メカニカル・アレイは経皮投与システムであり、極細の針をアレイ状に並べたもので、痛みを伴わずに皮膚外層に微小流路を形成します。この経路により、薬剤の真皮への直接輸送が促進され、低分子および高分子の薬剤の送達が可能になります。革新的なデザインは、皮膚からの高い薬物吸収を維持しながら、使用者の快適性を向上させるために進化してきました。皮膚からのドラッグデリバリーの強化には、熱アブレーションが用いられます。この技術は、温和な熱を利用して角質層に微細な孔を開け、一時的に浸透性を高めるものです。この方法は、マイクロニードルや化学増強剤などの他の技術と組み合わせることで、相乗的にパッチの効率と患者のコンプライアンスを向上させます。

用途:ホルモン療法における経皮吸収パッチの使用拡大

経皮吸収パッチによるホルモン療法は、内分泌治療における大きな進歩です。このパッチは、エストロゲンやテストステロンなどのホルモンを皮膚から直接血液中に投与するもので、血中濃度を一定に保つことができます。ほてりや骨粗鬆症予防を含む更年期障害の症状管理のためのホルモン補充療法(HRT)や、男性の性腺機能低下症などの症状に対するアンドロゲン補充療法で一般的に使用されています。過活動膀胱(OAB)に対する経皮吸収パッチは、抗コリン薬の目立たない使いやすい投与方法を提供することで、患者のQOLを大幅に改善します。このパッチは、頻尿、尿意切迫感、尿失禁などの過活動膀胱に伴う症状を軽減します。パッチから薬剤が徐放されることで、安定した一貫した治療効果が得られ、1日に何度も服用する必要性が最小限に抑えられ、全身的な副作用も軽減されます。慢性疼痛の管理は、経皮ドラッグデリバリーから多大な恩恵を受けています。非ステロイド性抗炎症薬(NSAIDs)、オピオイド、リドカインなどの鎮痛薬を含むパッチは、局所的あるいは全身的な鎮痛をもたらします。この方法では、鎮痛薬を数時間から数日間にわたって持続的に投与することができるため、一貫した疼痛管理が必要な患者や、経口投与が困難な患者、経口鎮痛薬による胃腸の副作用が大きい患者にとって特に有利です。経皮吸収型ニコチンパッチは、禁煙に伴う禁断症状や欲求の管理に役立ちます。ニコチンパッチは様々な用量があり、ユーザーは徐々にニコチン摂取量を減らすことができます。また、パッチによるニコチンの制御された放出は、喫煙に伴うニコチンの血中濃度の高いピークと谷を緩和し、よりスムーズな禁煙プロセスにつながります。

流通チャネル:Eコマースプラットフォームでの経皮吸収パッチの普及

経皮吸収パッチのオフライン流通は、主に実店舗の薬局、病院、クリニック、専門ドラッグストアなどです。これらのパッチは医薬品に分類され、流通に関して厳しい規制と管理があります。オフライン・チャネルは、アクセスしやすいという利点に加え、薬剤師や医療提供者による専門的な指導という付加価値があります。経皮吸収パッチのような、正しい使用方法について患者への教育が必要な製品には、このような個人的な交流が不可欠です。経皮吸収パッチのオンライン販売は、Eコマースや遠隔医療サービスの成長に後押しされ、増加傾向にあります。このチャネルは、消費者に利便性を提供し、しばしばコストを削減します。オンライン薬局や健康製品マーケットプレースは、患者が薬を入手するための慎重で時間効率の良い方法を提供し、ますます人気が高まっています。オンライン・プラットフォームは通常、在庫が豊富で、詳細な製品情報、レビュー、比較ツールを提供しています。

エンドユーザー:病院での経皮吸収パッチ処方の増加

クリニックは、主に臨床監督の必要性が最小であることから、これらのパッチの貴重なインターフェースとして機能しています。クリニックでは、軽度の病気やそれほど複雑でない健康状態が多いため、経皮吸収パッチを使用することが可能です。経皮吸収パッチは、ホルモン異常や慢性疼痛管理など、長期的なドラッグデリバリーが必要な外来診療において特に効果的です。在宅医療では、経皮吸収パッチは快適な自宅環境で継続的な投薬が必要な患者に対応します。高齢者を含む在宅患者や在宅介護を希望する患者は、非侵襲的な適用、投与量の一貫性、複数の薬剤を管理する必要がない利便性により、このパッチに利点を感じています。経皮吸収パッチは、ヘルスケア提供者が不在でも治療を継続することができます。病院では、経皮吸収パッチは入院・外来の両方で使用されています。重要な健康状態や慢性的な健康状態に対して、信頼性の高いコントロールされた薬物療法を提供します。また、入院患者の投薬スケジュールを容易にし、医療提供者の負担を軽減します。

地域別の洞察

南北アメリカでは、先進的なヘルスケアインフラ、高い医療費、慢性疾患の増加、新しい経皮技術の開発に積極的に取り組む主要企業の存在により、経皮吸収パッチ市場が発展しています。有利な規制政策と研究開発活動への強い注力は、南北アメリカにおける経皮吸収パッチ市場の成長に寄与しています。欧州は、経皮吸収パッチのような便利な薬物送達オプションを必要とする慢性疾患を持つ高齢者人口の増加により、経皮吸収パッチにとってもう一つの重要な市場です。欧州の政府やヘルスケア機関は、在宅医療のトレンドに合致した費用対効果の高い治療法を提唱しており、経皮吸収パッチのような自己管理型治療へのニーズを大きく後押ししています。中東・アフリカでは、医療インフラと経済発展により、エンドユーザーによる経皮吸収パッチの利用しやすさと採用率が向上しています。アジア太平洋は、ヘルスケア意識の向上と慢性疾患管理のニーズの高まりにより、経皮吸収パッチの急成長市場として浮上しています。ヘルスケアインフラの改善と所得水準の上昇が、アジア太平洋における経皮吸収パッチ市場の成長をサポートすると予測されています。

FPNVポジショニングマトリックス

FPNVポジショニングマトリックスは経皮吸収パッチ市場の評価において極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます:フォアフロント(F)、パスファインダー(P)、ニッチ(N)、バイタル(V)です。

市場シェア分析

市場シェア分析は、経皮吸収パッチ市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された蓄積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています:

1.市場の浸透度:主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度:有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化:新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報:市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5.製品開発およびイノベーション:将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています:

1.経皮吸収パッチ市場の市場規模および予測は?

2.経皮吸収パッチ市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か?

3.経皮吸収パッチ市場の技術動向と規制枠組みは?

4.経皮吸収パッチ市場における主要ベンダーの市場シェアは?

5.経皮吸収パッチ市場への参入に適した形態や戦略的手段は?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 世界中で慢性疾患の治療に経皮吸収パッチの使用が増加
      • 制御された薬物放出と非侵襲的なドラッグデリバリーソリューションへの関心の高まり
      • 経皮吸収パッチの政府承認数の増加
    • 抑制要因
      • 経皮吸収パッチに関連する高コスト
    • 機会
      • 先進的で高効率な経皮ドラッグデリバリーパッチの継続的な研究開発
      • 経皮吸収パッチの処方と製造における新たな進歩
    • 課題
      • 経皮吸収型医薬品の制限と製品リコール
  • 市場セグメンテーション分析
    • 製品:多層接着パッチの大幅な浸透
    • タイプ:ニコチン経皮吸収パッチに対する広範な要求
    • 技術:経皮パッチの効能を高める化学増強剤の利用
    • 用途:ホルモン療法における経皮吸収パッチの利用拡大
    • 流通チャネル:Eコマースプラットフォームにおける経皮吸収パッチの普及
    • エンドユーザー:病院での経皮吸収パッチの処方増加
  • 市場動向分析
    • 南北アメリカにおける経皮吸収パッチに対する政府の承認情勢
    • 慢性疼痛と糖尿病の罹患率の増加が、アジア太平洋での経皮吸収パッチの成長を促進
    • 欧州・中東・アフリカにおける革新的な経皮吸収パッチへのアクセスを増やすためのヘルスケアインフラの改善
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制枠組みの分析

第6章 経皮吸収パッチ市場:製品別

  • マトリックス
  • 多層薬剤含有貼付剤
  • リザーバー
  • 単層薬剤含有貼付剤

第7章 経皮吸収パッチ市場:タイプ別

  • ブプレノルフィン経皮パッチ
  • クロニジン経皮パッチ
  • フェンタニル経皮パッチ
  • ニコチン経皮パッチ
  • オキシブチニン経皮パッチ

第8章 経皮吸収パッチ市場:技術別

  • 化学強化剤
  • 電流
  • 機械アレイ
  • 熱アブレーション

第9章 経皮吸収パッチ市場:用途別

  • ホルモン療法
  • 過活動膀胱
  • 疼痛緩和
  • 喫煙の減少と禁煙の支援

第10章 経皮吸収パッチ市場:流通チャネル別

  • オフライン
  • オンライン

第11章 経皮吸収パッチ市場:エンドユーザー別

  • クリニック
  • 在宅ケア環境
  • 病院

第12章 南北アメリカの経皮吸収パッチ市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第13章 アジア太平洋の経皮吸収パッチ市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第14章 欧州・中東・アフリカの経皮吸収パッチ市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第15章 競合情勢

  • 市場シェア分析(2023年)
  • FPNVポジショニングマトリックス(2023年)
  • 競合シナリオ分析
    • DifGen Pharmaceuticalsは、米国の製造拠点 AvevaドラッグデリバリーSystemsから2番目の製品であるブプレノルフィン経皮吸収システムを発売。米国製の経皮吸収パッチおよび舌下フィルムの製造と販売のポートフォリオを拡大。
    • Luye Pharma Ltdが英国で新たなアルツハイマー病治療薬を発売
    • コルセア・ファーマ、肺動脈性高血圧症の臨床試験を進めるため2,300万米ドルのシリーズB資金調達を発表
    • Vaxess、mRNAワクチンパッチ開発を加速するため900万米ドルを調達
    • アルミラル、スペインでアルツハイマー病治療薬の販売権を4,500万ユーロで取得
    • コリウムとロータス製薬、革新的なアルツハイマー病治療薬ADLARITYのアジア複数市場での独占ライセンス契約を締結
    • デクスメデトミジン経皮パッチが術後疼痛管理に急遽承認
    • LTS、ソレルのウェアラブル注射デバイス事業の買収により高分子ドラッグデリバリーへの参入を完了
    • BioNxt、パーキンソン病治療薬ロチゴチン経皮パッチの欧州臨床試験の承認を取得
    • バイオクスト社、パーキンソン病治療薬ロチゴチン経皮パッチの臨床試験契約を締結し、臨床サンプルの製造を開始
    • LTSローマンが無針出産専門企業への投資を主導
    • Tesa Labtec GmbHの買収はAdhexPharmaの成長の礎となる

第16章 競合ポートフォリオ

  • 主要企業プロファイル
  • 主要製品ポートフォリオ
図表

LIST OF FIGURES

  • FIGURE 1. TRANSDERMAL PATCHES MARKET RESEARCH PROCESS
  • FIGURE 2. TRANSDERMAL PATCHES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. TRANSDERMAL PATCHES MARKET DYNAMICS
  • FIGURE 7. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 14. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 16. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2023 VS 2030 (%)
  • FIGURE 18. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 22. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 24. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 26. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 27. TRANSDERMAL PATCHES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 28. TRANSDERMAL PATCHES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. TRANSDERMAL PATCHES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY MATRIX, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY MULTI-LAYER DRUG-IN-ADHESIVE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY MULTI-LAYER DRUG-IN-ADHESIVE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY RESERVOIR, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY RESERVOIR, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY SINGLE-LAYER DRUG-IN-ADHESIVE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY SINGLE-LAYER DRUG-IN-ADHESIVE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY BUPRENORPHINE TRANSDERMAL PATCH, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY BUPRENORPHINE TRANSDERMAL PATCH, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY CLONIDINE TRANSDERMAL PATCH, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY CLONIDINE TRANSDERMAL PATCH, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY FENTANYL TRANSDERMAL PATCH, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY FENTANYL TRANSDERMAL PATCH, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY NICOTINE TRANSDERMAL PATCH, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY NICOTINE TRANSDERMAL PATCH, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY OXYBUTYNIN TRANSDERMAL PATCH, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY OXYBUTYNIN TRANSDERMAL PATCH, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY CHEMICAL ENHANCERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY CHEMICAL ENHANCERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY ELECTRIC CURRENT, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY ELECTRIC CURRENT, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY MECHANICAL ARRAYS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY MECHANICAL ARRAYS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY THERMAL ABLATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY THERMAL ABLATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 40. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 41. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY HORMONAL THERAPY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 42. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY HORMONAL THERAPY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 43. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY OVERACTIVE BLADDER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 44. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY OVERACTIVE BLADDER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 45. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY PAIN RELIEF, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 46. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY PAIN RELIEF, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 47. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY SMOKING REDUCTION & CESSATION AID, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 48. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY SMOKING REDUCTION & CESSATION AID, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 49. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 50. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 51. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY OFFLINE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 52. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY OFFLINE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 53. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY ONLINE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 54. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY ONLINE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 55. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 56. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 57. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 58. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 59. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 60. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 61. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 62. GLOBAL TRANSDERMAL PATCHES MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 63. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 64. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 65. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 66. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 67. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 68. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 69. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 70. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 71. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 72. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 73. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 74. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 75. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 76. AMERICAS TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 77. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 78. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 79. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 80. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 81. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 82. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 83. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 84. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 85. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 86. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 87. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 88. ARGENTINA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 89. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 90. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 91. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 92. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 93. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 94. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 95. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 96. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 97. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 98. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 99. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 100. BRAZIL TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 101. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 102. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 103. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 104. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 105. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 106. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 107. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 108. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 109. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 110. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 111. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 112. CANADA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 113. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 114. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 115. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 116. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 117. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 118. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 119. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 120. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 121. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 122. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 123. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 124. MEXICO TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 125. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 126. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 127. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 128. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 129. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 130. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 131. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 132. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 133. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 134. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 135. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 136. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 137. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 138. UNITED STATES TRANSDERMAL PATCHES MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 153. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 154. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 155. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 156. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 157. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 158. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 159. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 160. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 161. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 162. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 163. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 164. AUSTRALIA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 165. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 166. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 167. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 168. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 169. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 170. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 171. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 172. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 173. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 174. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 175. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 176. CHINA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 177. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 178. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 179. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 180. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 181. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 182. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 183. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 184. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 185. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 186. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 187. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 188. INDIA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 189. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 190. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 191. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 192. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 193. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 194. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 195. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 196. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 197. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 198. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 199. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 200. INDONESIA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 201. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 202. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 203. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 204. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 205. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 206. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 207. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 208. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 209. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 210. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 211. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 212. JAPAN TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 213. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 214. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 215. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 216. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 217. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 218. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 219. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 220. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 221. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 222. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 223. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 224. MALAYSIA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 225. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 226. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 227. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 228. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 229. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 230. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 231. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 232. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 233. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 234. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 235. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 236. PHILIPPINES TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 237. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 238. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 239. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 240. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 241. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 242. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 243. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 244. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 245. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 246. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 247. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 248. SINGAPORE TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 249. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 250. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 251. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 252. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 253. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 254. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 255. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 256. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 257. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 258. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 259. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 260. SOUTH KOREA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 261. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 262. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 263. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 264. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 265. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 266. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 267. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 268. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 269. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 270. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 271. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 272. TAIWAN TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 273. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 274. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 275. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 276. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 277. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 278. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 279. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 280. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 281. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 282. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 283. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 284. THAILAND TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 285. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 286. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 287. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 288. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 289. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 290. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 291. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 292. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 293. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 294. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 295. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 296. VIETNAM TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 299. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 300. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 301. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 302. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 303. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 304. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 305. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 306. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 307. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 308. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 309. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 310. EUROPE, MIDDLE EAST & AFRICA TRANSDERMAL PATCHES MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 311. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 312. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 313. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 314. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 315. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 316. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 317. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 318. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 319. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 320. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 321. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 322. DENMARK TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 323. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 324. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 325. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 326. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 327. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 328. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 329. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 330. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 331. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 332. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 333. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 334. EGYPT TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 335. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 336. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 337. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
  • TABLE 338. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
  • TABLE 339. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
  • TABLE 340. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 341. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 342. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 343. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2023 (USD MILLION)
  • TABLE 344. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024-2030 (USD MILLION)
  • TABLE 345. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2018-2023 (USD MILLION)
  • TABLE 346. FINLAND TRANSDERMAL PATCHES MARKET SIZE, BY END USERS, 2024-2030 (USD MILLION)
  • TABLE 347. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 348. FRANCE TRANSDERMAL PATCHES MARKET SIZE, BY PRODU
目次
Product Code: MRR-FD3F12D540F6

[198 Pages Report] The Transdermal Patches Market size was estimated at USD 8.57 billion in 2023 and expected to reach USD 9.89 billion in 2024, at a CAGR 16.40% to reach USD 24.84 billion by 2030.

Transdermal patches offer a novel therapeutic approach to managing chronic conditions by delivering medication directly through the skin into the bloodstream. These patches are used for a range of purposes, including nicotine cessation, hormone replacement therapy, pain management, and the administration of anti-hypertensive, anti-inflammatory, and contraceptive medications. The growing aging population facing difficulty in oral medication administration may benefit from the ease of use of transdermal patches. The prevalence of chronic diseases and the rising preference for non-invasive drug delivery methods are raising the need for transdermal patches. However, high costs and limitations associated with transdermal patches can impede end-user adoption. Moreover, ongoing R&D to develop innovative drug delivery systems and enhance the effectiveness and range of available transdermal drug delivery systems are expected to encourage their use to treat chronic conditions globally.

KEY MARKET STATISTICS
Base Year [2023] USD 8.57 billion
Estimated Year [2024] USD 9.89 billion
Forecast Year [2030] USD 24.84 billion
CAGR (%) 16.40%

Product: Significant penetration of Multi-layer Drug-in-Adhesive patches

The nicotine transdermal system is an established therapeutic option for tobacco cessation. It mitigates withdrawal symptoms and cravings in individuals attempting to quit smoking through the controlled release of nicotine without the harmful by-products of tobacco combustion. This system has demonstrated efficacy in improving long-term smoking abstinence rates and is considered an efficient pharmacotherapy for nicotine dependency, a chronic condition with significant health repercussions. Analgesic transdermal patches provide targeted and sustained pain relief, a critical component in the management of chronic pain conditions, including arthritis and neuropathic pain. Opioid patches containing drugs such as fentanyl offer potent analgesia for severe, intractable pain, usually in cancer patients. Non-opioid options, such as lidocaine patches, are used for localized symptoms, offering the advantage of minimal systemic side effects and reduced risk of dependence. Hormone Replacement Therapy (HRT) patches are used primarily for the treatment of menopausal symptoms and the prevention of osteoporosis. They are preferred by some patients over oral forms due to consistent blood concentration levels and reduced first-pass metabolism, minimizing potential side effects. Estrogen patches have significantly contributed to the quality of women experiencing postmenopausal symptoms. Antihypertensive transdermal patches release medication that helps control high blood pressure, a common chronic condition that can lead to cardiovascular disease if left unmanaged. These patches provide a steady absorption rate and maintain consistent plasma drug concentration, thereby avoiding blood pressure fluctuations. They are a viable option for patients with difficulties with oral dosing schedules, ensuring better compliance with treatment regimens. Emerging technologies in transdermal glucose management have shown potential for non-invasive blood sugar monitoring and insulin delivery, revolutionizing diabetes management. These technologies promise a convenient and painless alternative to conventional finger-prick tests and injections, potentially enhancing adherence to therapy and improving glycemic control for those with diabetes.

Type: Extensive requirement for nicotine transdermal patches

The buprenorphine transdermal patch is utilized for pain management. It is used in cases where an opioid analgesic is deemed necessary for an extended period. It offers the advantage of a reduced risk of abuse, side effects, and addiction compared to full opioid agonists. This patch is applied weekly, relieving pain while minimizing peak-and-trough fluctuations seen with oral dosing. The clonidine transdermal patch is designed for the treatment of hypertension. Clonidine is a central alpha agonist that decreases blood pressure by lowering the heart rate and relaxing blood vessels. The patch formulation allows for a steady medication administration over seven days, potentially resulting in improved patient compliance and reduced side effects associated with oral clonidine. Fentanyl is delivered through the skin through patches such as Duragesic. These patches are reserved for persistent, severe pain in patients accustomed to opioid treatment when alternative treatment options are inadequate. The fentanyl patch provides continuous pain relief over 72 hours, and due to the potency of fentanyl, careful patient selection and monitoring are critical to prevent potentially dangerous side effects, including respiratory depression. The nicotine transdermal patch administers a steady dose of nicotine to alleviate withdrawal symptoms and cravings associated with quitting smoking. It supports smokers to overcome addiction by providing a controlled reduction of nicotine exposure over several weeks or months. These patches are available in varying strengths to accommodate step-down therapy protocols. The oxybutynin transdermal patch serves patients suffering from overactive bladder characterized by symptoms such as urgency, frequency, and incontinence. Oxybutynin is an antimuscarinic agent that helps to relax bladder muscles. The patch allows consistent drug levels over three to four days, bringing about symptomatic relief while minimizing the anticholinergic side effects common to oral formulations.

Technology: Utilization of chemical enhancers to improve transdermal patch efficacy

Chemical enhancers are components incorporated into patch formulations to improve the solubility and permeability of drug molecules through the skin. These enhancers disrupt the skin's lipid matrix, aiding drug diffusion. Electric current or iontophoresis is a non-invasive method that implements a small electric charge to deliver a medicine or other chemical through the skin. It enhances drug penetration by electrophoretically moving ions across the skin, introducing the drug directly into the systemic circulation. This bypasses the detriments of first-pass metabolism, ensuring higher drug bioavailability. Mechanical arrays are a transdermal delivery system featuring arrays of minuscule needles that painlessly create microchannels in the skin's outer layer. These pathways enable an enhanced transportation of drugs directly into the dermis, assisting in delivering both small and macromolecular drugs. Innovative designs have evolved to improve user comfort while maintaining high drug absorption through the skin. Thermal ablation is used for enhancing drug delivery through the skin. This technique uses mild heat to create microscopic pores in the stratum corneum, temporarily increasing its permeability. This method is paired with other technologies, such as microneedles or chemical enhancers, synergistically increasing patch efficiency and patient compliance.

Application: Expanding use of transdermal patches for hormonal therapy

Hormonal therapy through transdermal patches is a significant advancement in endocrine treatments. These patches administer hormones such as estrogen or testosterone directly through the skin into the bloodstream, which helps maintain consistent blood levels. They are commonly used in hormone replacement therapy (HRT) for menopause symptom management, including hot flashes and osteoporosis prevention, and in androgen replacement therapy for conditions such as hypogonadism in men. Transdermal patches for overactive bladder (OAB) significantly improve patient's quality of life by providing a discreet and easy-to-use administration method for anticholinergic drugs. These patches reduce symptoms such as urinary frequency, urgency, and incontinence associated with OAB. The extended-release of medication from the patch ensures a stable and consistent therapeutic effect, minimizing the need for multiple daily doses and reducing systemic side effects. The management of chronic pain has benefited immensely from transdermal drug delivery. Patches containing analgesics, such as nonsteroidal anti-inflammatory drugs (NSAIDs), opioids, or lidocaine, provide localized or systemic pain relief. This modality allows for continuous delivery of analgesics over hours or days, which is particularly advantageous for patients requiring consistent pain management and those with difficulty with oral administration or experience substantial gastrointestinal side effects from oral analgesics. Transdermal nicotine patches help manage withdrawal symptoms and cravings associated with smoking cessation. Nicotine patches are available in various doses, allowing users to reduce their nicotine intake gradually. The controlled release of nicotine through the patch also mitigates the high peaks and troughs of nicotine blood levels that are with smoking, leading to a smoother cessation process.

Distribution Channel: Proliferation of transdermal patches on eCommerce platforms

The offline distribution of transdermal patches primarily encompasses brick-and-mortar pharmacies, hospitals, clinics, and specialty drug stores. These patches are classified as pharmaceutical products; they are subject to stringent regulations and controls in terms of distribution. Offline channels offer the advantage of accessibility, with the added value of professional guidance from pharmacists and healthcare providers. This personal interaction is instrumental for products such as transdermal patches, which may require patient education on correct usage. Online distribution of transdermal patches has been on the rise, fueled by the growth in eCommerce and telemedicine services. This channel provides convenience and often reduces costs for consumers. Online pharmacies and health product marketplaces have become increasingly popular, offering a discreet and time-efficient way for patients to obtain their medication. Online platforms usually have broader stock availability and provide detailed product information, reviews, and comparison tools.

End Users: Increasing prescription of transdermal patches in hospitals

Clinics serve as an invaluable interface for these patches, mainly due to their minimal requirement for clinical supervision. The predominance of minor ailments and less complex health conditions in clinics makes using transdermal patches feasible. They are especially effective in ambulatory care where long-term drug delivery is necessary, such as hormonal dysfunctions or chronic pain management. In-home care settings, transdermal patches cater to patients requiring continuous medication in the comfort of their home environment. Homebound patients or those preferring home care settings, including the elderly, find these patches advantageous due to the non-invasive application, the consistency of dosage, and the convenience of not managing multiple medications. Transdermal patches enable the continuation of treatment even in the absence of a healthcare provider. In hospitals, transdermal patches find utility for both inpatient and outpatient care. They offer reliable and controlled medication delivery for critical and chronic health conditions. They also facilitate easier medication schedules for inpatients, reducing a healthcare provider's burden.

Regional Insights

The transdermal patches market is developing in the Americas owing to the advanced healthcare infrastructure, high healthcare expenditure, increasing prevalence of chronic diseases, and the presence of key market players actively involved in developing new transdermal technologies. Favorable regulatory policies and a strong focus on research and development activities contribute to the transdermal patch market's growth in the Americas. Europe is another crucial market for transdermal patches owing to the increasing geriatric population with chronic conditions requiring convenient medication delivery options such as transdermal patches. Governments and healthcare organizations across Europe have been advocating for cost-effective treatment methods consistent with an at-home healthcare trend, significantly driving the need for self-administered therapies such as transdermal patches. Health infrastructure and economic developments are improving the accessibility and adoption of transdermal patches by end-users in the Middle East and Africa region. The Asia-Pacific region is emerging as the fastest-growing market for transdermal patches due to increasing healthcare awareness and the growing need for chronic disease management. Improvements in healthcare infrastructure and rising income levels are forecasted to support the growth of the transdermal patches market in the APAC region.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Transdermal Patches Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Transdermal Patches Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Transdermal Patches Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., AdhexPharma SAS, ALVOGEN, Amneal Pharmaceuticals, Inc., Bayer AG, BioNxt Solutions Inc., Bliss GVS Pharma Ltd., Boehringer Ingelheim International GmbH, Corium, Inc., Corsair Pharma, Inc., DifGen Pharmaceuticals LLC, Endo International plc, Gedeon Richter Plc, GlaxoSmithKline Plc, Icure Pharmaceutical Inc., Johnson & Johnson Services, Inc., LAVIPHARM GROUP HOLDING S.A., Luye Pharma Group Ltd, Medherant Limited, Nitto Denko Corporation, Novartis AG, Noven Pharmaceuticals, Inc. by Hisamitsu Pharmaceutical Co., Inc., Nutriband Inc, Perrigo Company plc, ProSolus, Inc., Purdue Pharma L.P., Sparsha Pharma International Pvt Ltd, Tapemark by LTS Lohmann Therapie-Systeme AG, Teikoku Seiyaku Co., Ltd., Tesa SE by Beiersdorf AG, Teva Pharmaceutical Industries Ltd., UCB S.A., Viatris Inc., and Zydus Group.

Market Segmentation & Coverage

This research report categorizes the Transdermal Patches Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Matrix
    • Multi-layer Drug-in-Adhesive
    • Reservoir
    • Single-layer Drug-in-Adhesive
  • Type
    • Buprenorphine Transdermal Patch
    • Clonidine Transdermal Patch
    • Fentanyl Transdermal Patch
    • Nicotine Transdermal Patch
    • Oxybutynin Transdermal Patch
  • Technology
    • Chemical Enhancers
    • Electric Current
    • Mechanical Arrays
    • Thermal Ablation
  • Application
    • Hormonal Therapy
    • Overactive Bladder
    • Pain Relief
    • Smoking Reduction & Cessation Aid
  • Distribution Channel
    • Offline
    • Online
  • End Users
    • Clinics
    • Home Care Settings
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Transdermal Patches Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Transdermal Patches Market?

3. What are the technology trends and regulatory frameworks in the Transdermal Patches Market?

4. What is the market share of the leading vendors in the Transdermal Patches Market?

5. Which modes and strategic moves are suitable for entering the Transdermal Patches Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increased use of transdermal patches to treat chronic conditions worldwide
      • 5.1.1.2. Rising preference for controlled drug release and non-invasive drug delivery solutions
      • 5.1.1.3. Growing number of government approvals for transdermal patches
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with transdermal patches
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing research and development for advanced and highly efficient transdermal drug delivery patches
      • 5.1.3.2. Emerging advances in the formulation and manufacturing of transdermal patches
    • 5.1.4. Challenges
      • 5.1.4.1. Limitations associated with transdermal drugs along with product recalls
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Significant penetration of Multi-layer Drug-in-Adhesive patches
    • 5.2.2. Type: Extensive requirement for nicotine transdermal patches
    • 5.2.3. Technology: Utilization of chemical enhancers to improve transdermal patch efficacy
    • 5.2.4. Application: Expanding use of transdermal patches for hormonal therapy
    • 5.2.5. Distribution Channel: Proliferation of transdermal patches on eCommerce platforms
    • 5.2.6. End Users: Increasing prescription of transdermal patches in hospitals
  • 5.3. Market Trend Analysis
    • 5.3.1. Supportive government approval landscape for transdermal patches in the Americas
    • 5.3.2. Growing prevalence of chronic pain and diabetes propelling the growth of transdermal patches in the APAC region
    • 5.3.3. Improving healthcare infrastructure to increase access of innovative transdermal patches in the EMEA region
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework Analysis

6. Transdermal Patches Market, by Product

  • 6.1. Introduction
  • 6.2. Matrix
  • 6.3. Multi-layer Drug-in-Adhesive
  • 6.4. Reservoir
  • 6.5. Single-layer Drug-in-Adhesive

7. Transdermal Patches Market, by Type

  • 7.1. Introduction
  • 7.2. Buprenorphine Transdermal Patch
  • 7.3. Clonidine Transdermal Patch
  • 7.4. Fentanyl Transdermal Patch
  • 7.5. Nicotine Transdermal Patch
  • 7.6. Oxybutynin Transdermal Patch

8. Transdermal Patches Market, by Technology

  • 8.1. Introduction
  • 8.2. Chemical Enhancers
  • 8.3. Electric Current
  • 8.4. Mechanical Arrays
  • 8.5. Thermal Ablation

9. Transdermal Patches Market, by Application

  • 9.1. Introduction
  • 9.2. Hormonal Therapy
  • 9.3. Overactive Bladder
  • 9.4. Pain Relief
  • 9.5. Smoking Reduction & Cessation Aid

10. Transdermal Patches Market, by Distribution Channel

  • 10.1. Introduction
  • 10.2. Offline
  • 10.3. Online

11. Transdermal Patches Market, by End Users

  • 11.1. Introduction
  • 11.2. Clinics
  • 11.3. Home Care Settings
  • 11.4. Hospitals

12. Americas Transdermal Patches Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Transdermal Patches Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Transdermal Patches Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2023
  • 15.2. FPNV Positioning Matrix, 2023
  • 15.3. Competitive Scenario Analysis
    • 15.3.1. DifGen Pharmaceuticals Launches A Second Product - Buprenorphine Transdermal System From Its U.S. Manufacturing Site Aveva Drug Delivery Systems; Expanding Its Portfolio Of Manufacturing & Marketing U.S. Made Transdermal Patches And Sublingual Films
    • 15.3.2. Luye Pharma Ltd Launches New Alzheimer's Treatment In The UK
    • 15.3.3. Corsair Pharma Announces USD 23 Million Series B Financing to Advance Clinical Trials in Pulmonary Arterial Hypertension
    • 15.3.4. Vaxess Raises USD 9 Million to Accelerate mRNA Vaccine Patch Development
    • 15.3.5. Almirall Acquires Rights To Distribute Alzheimer's Treatment In Spain For An Initial EUR 45 Million
    • 15.3.6. Corium and Lotus Pharmaceutical Enter into Exclusive License Agreement for Innovative Alzheimer's Disease Treatment ADLARITY in Multiple Markets Across Asia
    • 15.3.7. Dexmedetomidine Transdermal Patch Fast Tracked for Postop Pain Management
    • 15.3.8. LTS Completes its Entry into Large Molecule Drug Delivery with the Acquisition of the Sorrel Wearable Injection Device Business
    • 15.3.9. BioNxt Receives Approval for European Clinical Study of Transdermal Rotigotine Patch for Parkinson's Disease
    • 15.3.10. Bionxt Signs Clinical Study Agreement and Commences Manufacture of Clinical Samples for Study of Transdermal Rotigotine Patch for Parkinson's Disease
    • 15.3.11. LTS Lohmann Leads Investment in Needle-Free Delivery Specialist
    • 15.3.12. The Addition of Tesa Labtec GmbH Marks a Cornerstone in AdhexPharma's Growth Path

16. Competitive Portfolio

  • 16.1. Key Company Profiles
  • 16.2. Key Product Portfolio